Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Cash Earnings per Share (CEPS)

    Back to All Ratios
AD     Remove this Ad

BAL PHARMA Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   CEPS(Rs) 10.6811.087.499.959.60

What is the latest Cash Earnings per Share (CEPS) ratio of BAL PHARMA ?

The latest Cash Earnings per Share (CEPS) ratio of BAL PHARMA is 10.68 based on Mar2025 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar202510.68
Mar202411.08
Mar20237.49
Mar20229.95
Mar20219.60

How is Cash Earnings per Share (CEPS) of BAL PHARMA Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2025 10.68
-3.61
Mar2024 11.08
47.93
Mar2023 7.49
-24.72
Mar2022 9.95
3.65
Mar2021 9.6 -

Other Financial Ratios of BAL PHARMA


Compare Cash Earnings per Share (CEPS) ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹106.8 Cr 0.2% -7.5% -36.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,694.0 Cr -2.3% -7.3% -12.8% Stock Analytics
DIVIS LABORATORIES ₹160,721.0 Cr 0.8% -5.8% 4.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,016.0 Cr 0.8% 3.7% 20.8% Stock Analytics
CIPLA ₹106,946.0 Cr 0.7% -11.2% -6.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,691.0 Cr -1.4% -3.8% -1.3% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

0.2%

-7.5%

-36.7%

SENSEX

-0.1%

-2.9%

7.5%


You may also like the below Video Courses